|
|
The Impact of the Metabolic Syndrome on Cardiovascular Risk and Disease in Rheumatoid Arthritis
|
| Link ID |
9567 |
| Title |
The Impact of the Metabolic Syndrome on Cardiovascular Risk and Disease in Rheumatoid Arthritis |
| Url |
http://www.medscape.com/viewarticle/581366?src=rss |
| Description |
The metabolic syndrome is a cluster of cardiovascular risk factors that are of metabolic origin, and include atherogenic dyslipidemia, hypertension, and hyperglycemia. In RA patients, several other factors increase the risk of developing the syndrome.
Future Rheumatology |
| Category |
Articles > Rheumatology |
| Keywords |
|
| Date |
Oct 11, 2008 |
| Contact Name |
|
| Email |
|
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|
|
Other links at Articles > Rheumatology |
| 2. |
Excellent Results With Early, Aggressive Treatment in RA
|
|
|
Continuous methotrexate and intra-articular corticosteroids can achieve "excellent clinical response and disease control after 2 years" in patients with early rheumatoid arthritis (RA), Danish investigators report in the June issue of the Annals of Rheumatic Diseases. Reuters Health Information
|
| 4. |
Golimumab Effective for Refractory Rheumatoid Arthritis
|
|
|
A long-acting monoclonal antibody to TNF-alpha, golimumab, is effective in treating patients with active rheumatoid arthritis despite treatment with methotrexate, according to a report in the April issue of Arthritis & Rheumatism. Reuters Health Information
|
|
|
